Cancel
ANI Pharmaceuticals
ANI Pharmaceuticals Employees
9 people indexed:
-
Chad Gassert
Sr. Vice President, Corporate Development and Strategy
x40f.xjqf4bj@00j884vyyz22jw1qx2.bz2 Sign up to see emailf8x5.v476zw7@744794792x2kkvyfv6.bww Sign up to see email -
9jjwfqy34d.k8xv@wwkv12dwd8w04x0280.q50 Sign up to see email
-
James G. Marken
Sr. Vice President, Operations and Product Development
4241d.d.76v0vf@6d7q387w51b9xw8985.675 Sign up to see email7492z.4.zy45zx@091w6x9y48b60vzf6d.xd7 Sign up to see email -
98yzb7.1749x@gw64xgww4704xf43y3.w5g Sign up to see email
-
Meredith W. Cook
Senior Vice President, General Counsel and Corporate Secretary
g1297x3j.2.1z91@56qx8g8z763711v5yx.qxx Sign up to see email5j7y9qz7.z.7fzx@bv53ybgxf48yf7z065.bjg Sign up to see email -
Muthusamy 'Samy' Shanmugam
Head of R&D and COO of NJ Operations
62q81z0fq.95jf.zw7f8v0qb@kk0w55vq0w27675b52.0bz Sign up to see emailkxd73fqq4.vwkw.qq88fkx73@bdfdvx7f51vv8kdwv0.45j Sign up to see email -
Nikhil Lalwani
President and Chief Executive Officer
gbzxzd.vbfg7v3@gj3z8xz4j5y46z2d5x.359 Sign up to see email900vv2.31z050y@646888zz3zf18dx2fj.5gb Sign up to see email -
Ori Gutwerg
Senior Vice President of Generics
795.x99j55b@fkfj0j11k1y0jd7y3d.9xx Sign up to see email806.5q9q3b0@f22zzv9y3bk397vxf5.0v6 Sign up to see email -
Stephen P. Carey
Senior Vice President and Chief Financial Officer
61f70k2.5.j352x@bf150b4vkf412xgdz0.764 Sign up to see emailb0343q0.v.596w5@7qkvk566b332z972fk.6gw Sign up to see email
ANI Pharmaceuticals Company Information
ANI Pharmaceuticals, headquartered in Baudette, Minnesota, operates a 47,000 sq. ft. containment facility focused on the manufacturing of potent actives. The company offers a comprehensive portfolio of pharmaceutical products, encompassing branded and generic prescription pharmaceuticals. Notably, ANI Pharmaceuticals launched Baclofen Oral Suspension, a generic version of Fleqsuvy, which generates annual U.S. sales of approximately $39 million. The acquisition of Novitium Pharma has enhanced ANI’s research and development capabilities, as well as expanded its scale in generics and Contract Development and Manufacturing Organization (CDMO) businesses. The company’s manufacturing capabilities include granulation, tablet pressing, and coating, alongside specialized services such as containment manufacturing and packaging for potent actives. Additionally, ANI provides contract packaging services, equipped with blister packaging capabilities and a fully automated solid dose packaging line with serialization.
Report inaccurate information
Report inaccurate information
